186 related articles for article (PubMed ID: 37909399)
1. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
Vereb M; Atkins CE; Adin D; Blondel T; Coffman M; Lee S; Guillot E; Ward JL
J Vet Intern Med; 2024; 38(1):51-60. PubMed ID: 37909399
[TBL] [Abstract][Full Text] [Related]
2. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
Morgan KRS; Monteith G; Raheb S; Colpitts M; Fonfara S
Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487
[TBL] [Abstract][Full Text] [Related]
4. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
Caivano D; Rishniw M; Birettoni F; Patata V; Giorgi ME; Porciello F
J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of selected one-, two- and three-dimensional and Doppler echocardiographic methods to assess severity in dogs with myxomatous mitral valve disease.
Tidholm A; Häggström J
J Vet Cardiol; 2022 Feb; 39():89-101. PubMed ID: 35008002
[TBL] [Abstract][Full Text] [Related]
6. Two radiographic methods for assessing left atrial enlargement and cardiac remodeling in dogs with myxomatous mitral valve disease.
Vezzosi T; Puccinelli C; Citi S; Tognetti R
J Vet Cardiol; 2021 Apr; 34():55-63. PubMed ID: 33581663
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease.
Malcolm EL; Visser LC; Phillips KL; Johnson LR
J Am Vet Med Assoc; 2018 Oct; 253(8):1038-1045. PubMed ID: 30272515
[TBL] [Abstract][Full Text] [Related]
8. Use of radiographic measurements to diagnose stage B2 preclinical myxomatous mitral valve disease in dogs.
Stepien RL; Rak MB; Blume LM
J Am Vet Med Assoc; 2020 May; 256(10):1129-1136. PubMed ID: 32364449
[TBL] [Abstract][Full Text] [Related]
9. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
Dickson D; Caivano D; Matos JN; Summerfield N; Rishniw M
J Vet Cardiol; 2017 Dec; 19(6):469-479. PubMed ID: 29111284
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.
Boswood A; Gordon SG; Häggström J; Vanselow M; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Schummer C; Watson P
J Vet Intern Med; 2020 May; 34(3):1108-1118. PubMed ID: 32200574
[TBL] [Abstract][Full Text] [Related]
11. The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs.
Vezzosi T; Grosso G; Tognetti R; Meucci V; Patata V; Marchesotti F; Domenech O
J Vet Intern Med; 2021 May; 35(3):1238-1244. PubMed ID: 33951235
[TBL] [Abstract][Full Text] [Related]
12. Change of Vertebral Left Atrial Size in Dogs With Preclinical Myxomatous Mitral Valve Disease Prior to the Onset of Congestive Heart Failure.
Lee D; Yun T; Koo Y; Chae Y; Ku D; Chang D; Kang BT; Yang MP; Kim H
J Vet Cardiol; 2022 Aug; 42():23-33. PubMed ID: 35675727
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study.
Borgarelli M; Ferasin L; Lamb K; Chiavegato D; Bussadori C; D'Agnolo G; Migliorini F; Poggi M; Santilli RA; Guillot E; Garelli-Paar C; Toschi Corneliani R; Farina F; Zani A; Dirven M; Smets P; Guglielmini C; Oliveira P; Di Marcello M; Porciello F; Crosara S; Ciaramella P; Piantedosi D; Smith S; Vannini S; Dall'Aglio E; Savarino P; Quintavalla C; Patteson M; Silva J; Locatelli C; Baron Toaldo M
J Vet Cardiol; 2021 Aug; 36():77-88. PubMed ID: 34118562
[TBL] [Abstract][Full Text] [Related]
14. Radiographic quantification of left atrial size in dogs with myxomatous mitral valve disease.
Lam C; Gavaghan BJ; Meyers FE
J Vet Intern Med; 2021 Mar; 35(2):747-754. PubMed ID: 33634912
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic predictors of survival in dogs with myxomatous mitral valve disease.
Sargent J; Muzzi R; Mukherjee R; Somarathne S; Schranz K; Stephenson H; Connolly D; Brodbelt D; Fuentes VL
J Vet Cardiol; 2015 Mar; 17(1):1-12. PubMed ID: 25586168
[TBL] [Abstract][Full Text] [Related]
16. Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019-2021): 98 cases.
Matson H; Llewellyn EA
J Vet Emerg Crit Care (San Antonio); 2024; 34(3):231-237. PubMed ID: 38809224
[TBL] [Abstract][Full Text] [Related]
17. Use of vertebral left atrial size for staging of dogs with myxomatous valve disease.
Mikawa S; Nagakawa M; Ogi H; Akabane R; Koyama Y; Sakatani A; Ogawa M; Miyakawa H; Shigemoto J; Tokuriki T; Toda N; Miyagawa Y; Takemura N
J Vet Cardiol; 2020 Aug; 30():92-99. PubMed ID: 32707334
[TBL] [Abstract][Full Text] [Related]
18. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
19. Utility of radiographic measurements to predict echocardiographic left heart enlargement in dogs with preclinical myxomatous mitral valve disease.
Poad MH; Manzi TJ; Oyama MA; Gelzer AR
J Vet Intern Med; 2020 Sep; 34(5):1728-1733. PubMed ID: 32686167
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.
Baron Toaldo M; Romito G; Guglielmini C; Diana A; Pelle NG; Contiero B; Cipone M
J Vet Intern Med; 2018 May; 32(3):914-921. PubMed ID: 29572938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
